aod9604 dosing frequency subcutaneous injection Safety and Tolerability of the Hexadecapeptide AOD 9604 in Humans December 4, 2024 Pharmacy Compounding

Others use a week-based system, using the right side on odd days and left side on even days

In the future, AOD 9604 is expected to become an important drug in the field of local fat reduction, providing a safer and more effective treatment option for obese patients

Clinical trials showed an average loss of 6 pounds over 12 weeks compared to 2 pounds with placebo

AOD 9604 works through direct activation of fat cell receptors, bypassing appetite signaling entirely

Standard reconstitution for AOD-9604 AOD-9604 typically arrives as lyophilized (freeze-dried) powder in sealed vials, most commonly in 2mg or 5mg quantities